Federated Hermes’s Oramed Pharmaceuticals ORMP Stock Holding History

Federated Hermes’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.2K	Buy	+3,996	New	+$15.9K	﹤0.01%	1784
2024 Q1	–	Sell	-369	Closed	-$852	–	2103
2023 Q4	$852	Buy	369 +247	+202%	+$528	﹤0.01%	1985
2023 Q3	$318	Buy	+122	New	+$384	﹤0.01%	2059
2023 Q2	–	Sell	-684	Closed	-$1.49K	–	2189
2023 Q1	$1.49K	Buy	+684	New	+$2.17K	﹤0.01%	2022
2021 Q3	–	Sell	-439	Closed	-$6K	–	2289
2021 Q2	$6K	Buy	+439	New	+$5.02K	﹤0.01%	2023
2020 Q2	–	Sell	-536	Closed	-$2K	–	2340
2020 Q1	$2K	Buy	+536	New	+$2.35K	﹤0.01%	2026

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes's ORMP Position: Q2 2026 in Review

Federated Hermes opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 3,996 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #1784 among its holdings. This is a return to the name: Federated Hermes previously reported a position in ORMP as recently as Q4 2023.

Federated Hermes first reported a position in ORMP in Q1 2020 and has held it in 6 quarters since. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

Federated Hermes held 3,996 shares of Oramed Pharmaceuticals worth $19.2K as of Q2 2026.
Oramed Pharmaceuticals was a new Federated Hermes position in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1784 holding.
Federated Hermes first reported a position in Oramed Pharmaceuticals in Q1 2020 and has held it in 6 quarters since.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.